Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Market update

4 Jan 2017 07:00

RNS Number : 2611T
FastForward Innovations Limited
04 January 2017
 

3 January 2017

 

 

FastForward Innovations Ltd

("FastForward" or the "Company")

Market Update

Proposed Recommended Offer for Schoold

Proposed Listing of Leap Gaming

Proposed Recommended Offer for the issued shares of Schoold

 

The Company is pleased to announce that Vested Finance Inc. ("Schoold"), the US incorporated education technology provider trading under the brand "Schoold", and Mr Lorne Abony (the largest shareholder of Schoold and Chief Executive Officer of FastForward), have executed a term sheet with a strategic acquirer regarding a proposed recommended offer for the entire issued share capital of Schoold. The offer places a value on Schoold representing an increase in the reported value of FastForward's investments in Schoold at the time of FastForward's interim report and accounts to 31 September 2016.

 

The Term Sheet provides for a 75-day period of exclusivity in relation to the proposed acquisition which is subject to definitive agreements being concluded by the parties.

 

The Company has an approximate 12.3 per cent. interest (on a fully diluted basis) in the issued shares of Schoold.

 

Proposed Listing of Leap Gaming

 

The Company has been informed by Frallis LLC ("Leap Gaming") that it has started the process of seeking a listing of its shares on a North American stock exchange. In addition, Leap Gaming has confirmed that it has received an approach from an existing partner regarding a possible cornerstone investment in the business ahead of a proposed IPO of such partner and this party is currently undertaking a valuation exercise that will determine proposed pricing of Leap Gaming. Leap Gaming has indicated that it expects that either transaction, if completed, would represent in an increase over the reported value of FastForward's investments in Leap Gaming at the time of FastForward's interim report and accounts to 31 September 2016.

 

Leap Gaming is currently in the process of engaging advisers ahead of the proposed IPO which is expected to complete in the first half of 2017.

 

The Company can give no guarantee that an IPO will be completed or the valuation at which such IPO will occur. The Board of FastForward is however supportive of the proposed steps and will look to support Leap Gaming management over the course of the next few months.

 

The Company has an approximate 41.15 per cent. interest (on a fully diluted basis) in the issued shares of Leap Gaming, making it the largest shareholder of the company.

 

Commenting on the good news to start 2017, Lorne Abony noted, "The excellent news regarding Schoold and Leap Gaming over the holiday period ends a successful 2016 for the Company, and first 12 months for me personally as Chief Executive Officer. We continue to see significant milestones being achieved in all our investee companies (and do our best to bring the good news to all our shareholders through regular updates), and believe 2017 will be a year when a lot of hard work begins to pay off for FastForward, and for the respective management teams working so hard to drive the investee businesses forward."

 

Market Abuse Regulations

 

The Directors of the Company consider each of the transactions above to be at an advanced stage of negotiation, and to be material to the business, trading and operations of the Company, constituting price sensitive inside information for the purposes of Market Abuse Regulation (EU) No. 596/2014.

For further information please visit www.fstfwd.co or contact:

FastForward Innovations Limited

info@fstfwd.co

Josh Epstein / Ian Burns

 

Peel Hunt LLP

+44 (0)20 7418 8900

Dan Webster / Adrian Trimmings / George Sellar

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of Fast Forward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Fast Forward Innovations assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDOKNDDKBKBDDK
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.